| 000 | 05323cam a2200433Ii 4500 | ||
|---|---|---|---|
| 001 | 95870 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112725.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170426s2017 sz a o 001 0 eng d | ||
| 020 |
_a3319538802 _q(electronic bk.) |
||
| 020 |
_a9783319538808 _q(electronic bk.) |
||
| 020 | _z3319538799 | ||
| 020 |
_z9783319538792 _q(print) |
||
| 040 |
_aN$T _cN$T _dGW5XE _dN$T _dEBLCP _dYDX _dUAB _dMERER _dESU _dAZU _dUPM _dIOG _dOCLCF _dOCLCO _dCOO _dOCLCQ _dOTZ _dVT2 _dSTF _dOCLCO _dOCLCQ _dJG0 _dOCLCO _dOCLCA _dU3W _dOCLCO _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRS431.A64 _bB568 2017 EB |
|
| 066 | _c(S | ||
| 245 | 0 | 0 |
_aBiotechnology and production of anti-cancer compounds _cSonia Malik, editor. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c2017. |
|
| 300 |
_a1 recurso en línea (xv, 328 páginas) _bilustraciones (algunas a color) |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 500 | _aIncluye índice | ||
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 505 | 0 |
_6880-01 _aDedication; Preface; Acknowledgments; Contents; Contributors; Chapter 1: Medicinal Plants: Ethno-Uses to Biotechnology Era; Historical Background; Ethnomedicines Uses of Herbs Between the Past and the Present; Ancient Times; In Egypt; In Greece; In China; In India; Middle Ages; Arabic Achievements in Herbal Medicine; Modern Era; Early Modern Era; Turning Points in the Use of Medicinal Plants; Importance of Medicinal Plants Has Increased Recently ... Why?; Why the Need Arises to Search for New Sources of Drugs?; Economic Returns for the Use of Medicinal Plants. |
|
| 505 | 8 | _aChapter 2: How Plants Can Contribute to the Supply of Anticancer Compounds Introduction; Plant Secondary Metabolites as Anticancer Drugs; Natural Sources of Plant Metabolites with Anticancer Activity; Production of Small-Molecule Anticancer Compounds in Plants; Protein-Based Anticancer Compounds from Plants; Anticancer Activity of Lectins; Recombinant Protein Expression in Plants; Benefits and Challenges; Product Recovery and Purification; Process Design and Monitoring; Transgenic Plants and the Potential Large-Scale Production of Anticancer Compounds. | |
| 505 | 8 | _aHow to Use the Herbal Medicines? Awareness in the Use of Medicinal Plants; Regulation and Legislation of Herbal Medicines; Medicinal Plants Were Used Traditionally to Heal from Cancer: Why? and How?; Why People Use Herbal Medicine with Cancer?; Medicinal Plants: Cancer Remedies Between the Past and the Present; Herbal Medicines: Traditional Treatment of Cancer Worldwide; New Vision of Medicinal Plants by Biotechnological Lenses; How Will the Medicinal Plants Be Drugs?; Background of Knowledge; Plant Selection; Preparation and Isolation of Bioactive Substances. | |
| 505 | 8 | _aThe Need of Pharmacological Validation Benefits of Applying Biotechnology in Medicinal Plants; Why It Has Increased the Need to Apply Biotechnology to Medicinal Plants?; What Are the Advantages of Applied Biotechnological Techniques?; Trace Medicinal Plants from Field to Fork by Biotech Approaches ... Is It Possible?; Determine the Geographical Origin of Herbal Materials Is Vital Requirement ... Why?; Current Techniques Used for Determining the Origin of Medicinal Plants; PCR-DGGE: Innovative Biological Barcode of Medicinal Plants; Conclusion and Future Prospects; References. | |
| 520 | 3 | _aThis book discusses cancers and the resurgence of public interest in plant-based and herbal drugs. It also describes ways of obtaining anti-cancer drugs from plants and improving their production using biotechnological techniques. It presents methods such as cell culture, shoot and root culture, hairy root culture, purification of plant raw materials, genetic engineering, optimization of culture conditions as well as metabolic engineering with examples of successes like taxol, shikonin, ingenol mebutate and podophylotoxin. In addition, it describes the applications and limitations of large-scale production of anti-cancer compounds using biotechnological means. Lastly, it discusses future economical and eco-friendly strategies for obtaining anti-cancer compounds using biotechnology. | |
| 650 | 7 |
_aAntineoplásicos _2embne _0(OCoLC)fst00810595 _0 _9405304 |
|
| 700 | 1 |
_aMalik, Sonia, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-53880-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 880 | 8 |
_6505-01/(S _aScalability and Product Quality Monoclonal Antibodies; Lectins; Anticancer Vaccines; Transient Expression Systems for Individualized Cancer Therapies; Conclusions; References; Chapter 3: Cancer and Biotechnology: A Matchup that Should Never Slowdown; Introduction; Cancer Stem Cells; CSCs Self-Renewal Pathways; Wnt/β-Catenin Pathway; Notch Pathway; Hedgehog Pathway; CSCs Niche; Hypoxia; Inflammation; Three-Dimensional Tumor Spheroid Models; Cytotoxic and Antiproliferative Effects of Natural Products and Derivatives Against Tumor Spheroid Models. |
|
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017C | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95870 _d95870 _x1 |
||